ACPHS-52

N/A

Report date: 2025/01/26 15:32:45
NME

Base Information

Drug NameACPHS-52
Drug Alias NameRBP4 antagonist (Columbia University Medical Center/Rensselaer Polytechnic Institute)ACPHS-52
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRetinol-binding protein 4 inhibitors
TargetsRetinol-binding protein 4
Therapy Area/IndicationsMacular DegenerationStargardt Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesColumbia University Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesRensselaer Polytechnic InstituteColumbia University Medical Center
Inactive CompaniesN/A
Active IndicationsMacular DegenerationStargardt Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A